Multiple Ascending Dose Study to Evaluate the Safety, Tolerability of DC371739 Treatment in Hypercholesterolemic
Status:
Recruiting
Trial end date:
2021-10-31
Target enrollment:
Participant gender:
Summary
This study is to evaluate safety, tolerability, pharmacokinetics and pharmacodynamics of
DC739 after multiple-dose oral administration, to explore the clinical effective dose, and to
initially explore the efficacy and safety in hypercholesterolemia subjects.